Repligen | RGEN - 流动资产



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.26B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


流动资产 更改 日
Agilent USD 4.76B 148M 2026-03
Align Technology USD 2.66B 7.62M 2026-06
Bio Techne USD 688.05M 50.62M 2026-03
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Bruker USD 2.22B 121.4M 2026-06
Charles River Laboratories USD 1.53B 40.3M 2026-06
Danaher USD 13.38B 554M 2026-06
Dentsply International USD 1.93B 83M 2026-06
General Electric Aerospace USD 39.7B 664M 2026-06
Henry Schein USD 4.6B 104M 2026-06
Illumina USD 2.83B 96M 2026-06
IQVIA Holdings USD 6.23B 6M 2026-06
Mettler Toledo International USD 1.35B 15.48M 2026-06
Myriad Genetics USD 289M 23.8M 2026-06
OraSure Technologies USD 222.94M 17.84M 2026-06
Pacific Biosciences Of California USD 338.64M 30.88M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Repligen USD 1.2B 39.19M 2026-06
Revvity USD 2.3B 169.4M 2026-06
Standard Biotools USD 521.45M 67.19M 2026-03
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
Waters USD 3.9B 186M 2026-06
West Pharmaceutical Services USD 1.81B 19.3M 2026-06